3D illustration of artificial insemination or in vitro fertilization.

Analyzing the media used to culture embryos fertilized in vitro adds to the toolbox of human embryo quality assessments.

credit: iStock.com/iLexx

Noninvasive genetic analysis boosts embryo quality checks

The spent media of human embryo cultures may hold clues that help doctors distinguish normal embryos from abnormal ones.
Luisa Torres
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

Reproductive endocrinologist Irene Su and her collaborator Sheng Zhong, a biostatistician at the University of California, San Diego, routinely perform liquid biopsies on recovered cancer patients to track cancer regression. In 2019, using minuscule amounts of serum, they identified specific signatures that could identify patients with or without recurrent breast cancer. A few years later, they realized that they could try a similar method to distinguish viable human embryos from abnormal ones after in vitro fertilization (IVF). 

Scientist Irene Su wears a white lab coat embroidered with "UC San Diego Medical Center.
Irene Su and colleagues used the spent media from cultured IVF embryos to identify extracellular RNA signatures that could complement embryo morphological assessment.
credit: Department of Obstetrics, Gynecology and Reproductive Sciences University of California, San Diego

In a recent study published in Cell Genomics, their research team reported a non-invasive method for inspecting human embryo quality using up to 40 µl of embryo culture medium (2). Their technique complements existing technologies for assessing embryo quality and may one day improve the predictions that an embryo will result in a live birth. “Being able to make meaningful measurements from a small amount of input material opens the door for better diagnostics for IVF in the future,” said Rajiv McCoy a biologist at Johns Hopkins University who was not involved in the study. 

Currently, doctors rely on embryo morphology assessments and preimplantation genetic testing to predict which embryos are most likely to develop to term, but these methods are imperfect. “The live birth rate, even after preimplantation genetic testing, is somewhere between 70-75 percent,” said Su. “That's awesome, but we can’t explain why we don’t have a live birth in 25-30 percent of cases.” This uncertainty raises the question of whether analyzing spent media, which is typically discarded, could provide additional insights about embryo development.

As human IVF embryos develop in culture, they release part of their RNA into the extracellular space. The researchers wanted to identify specific extracellular RNA signatures that correlated with known measures of human embryo quality. They began by collecting small media samples from the cultured IVF embryos of 29 participants and performed extracellular RNA sequencing to construct sequencing libraries. They detected around 4,000 RNA molecules at each stage of embryonic development, including the oocyte, zygote, 8-cell, morula, and blastocyst stages.

To correlate extracellular RNA profiles with embryo quality, an embryologist assessed IVF embryos at 120- and 160-hours post-fertilization and categorized them as either developing normally or developmentally arrested. The team then analyzed the culture media from these and found that the developmentally arrested embryos had a distinct extracellular RNA profile characterized by lower overall extracellular RNA levels, but higher levels of specific genes known to negatively regulate cell-cycle progression. 

The live birth rate, even after preimplantation genetic testing, is somewhere between 70- 75 percent. That's awesome, but we can’t explain why we don’t have a live birth in 25-35 percent of cases. 
– Irene Su, University of California, San Diego

Lastly, an embryologist graded embryos based on their morphology, with blastocysts receiving ratings of good, fair, or poor. Initial analysis showed that no single gene could predict embryo quality when considered independently, but a machine-learning model showed a strong correlation between predicted and observed quality scores and identified genes associated with embryo quality. These genes were related to GTPase activity regulation and spindle structure, which are both important for asymmetric cell division.

The researchers used spent media from cocultured embryos, which is considered best practice in IVF. This prevented the association of specific findings with individual embryos. “The practical value of this study is limited at this time, but it's a nice proof of principle that you can get RNA sequencing data out of a small amount of material, and that it's correlated with measurements of embryo quality,” said McCoy.

In future experiments, Su and Zhong plan to correlate the extracellular RNA signatures with preimplantation genetic testing results and test whether this information adds to live birth predictions. “This study draws attention to the idea of coming up with noninvasive ways to improve predictions about pregnancy outcomes,” said McCoy. “It’s a small step toward that goal.”

References

  1. Zhou, Z. et al. Extracellular RNA in a single droplet of human serum reflects physiologic and disease states. Proc Natl Acad Sci  116, 19200–19208 (2019).
  2. Wu, Q. et al. A temporal extracellular transcriptome atlas of human pre-implantation development. Cell Genomics  4, 100464 (2024).

About the Author

  • Luisa Torres
    Luisa is an assistant science editor at Drug Discovery News. She is a PhD in Molecular and Cellular Pharmacology from Stony Brook University who has written for NPR’s science desk.

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue